Description: U.S. Individual Life COVID-19 Mortality Claims Analysis

Description: Term Life insurance is a popular product in the U.S. As a growing number of policyholders have been reaching the end of the level term period, the SOA has been committed to studying policyholder behavior in the post-level term (PLT). Shock lapse, post-level term lapse and mortality have previously been analyzed in SOA PLT studies conducted in 2010 and 2014. This study provides an update of experience and some valuable new insights.

Description: The COVID-19 (COVID) pandemic has increased the demand for data and analysis on the impact of COVID on U.S. population mortality. This report is based on 2020 provisional death data released by the CDC. The SOA plans to update this report after additional 2020 cause of death data in released by the CDC later in 2021.

Description: In this report, we consider high-level results from provisional mortality data released from the U.S. Centers for Disease Control and Prevention (CDC) for 2021, including looking at changes by sex and age group.

Description: This report provides various summaries of the above listed data and provides observations from these summaries, with a goal to help actuaries understand the emerging trends in mortality due to COVID-19.

Description: This report is an update of the U.S. Population Mortality Observations – Preview of 2020 Experience released in May 2021. This update is based on 2020 provisional death data released by the CDC.

Description: The Society of Actuaries (SOA) Research Institute, LIMRA, Reinsurance Group of America (RGA) and TAI recently released an update to the U.S. Individual Life COVID-19 report series. This report is the third public release from this collaboration and contains the results of an excess mortality analysis for the four quarter of 2020. Data from 31 companies representing approximately 72% of the industry’s face amount inforce have been included in the analyses in this report. A total of 2.9 million death claims from individual life policies from 2015 through December 31, 2020 make up the basis of the analyses.

Description: In the third quarter of 2022, publicly traded life insurers reported on their financial and operational activities, which included a downturn in income from alternative investments, the continuing impact of COVID, the impact of equity market returns on variable annuity products, and growth trends related to pension risk transfer transactions.

Description: In the second quarter of 2022, publicly traded life insurers reported some of their best financial results since the pandemic began. COVID-19-related claims fell sharply in many product categories. Sales, which had taken a big hit, showed significant improvement as well, though not always to pre-pandemic levels. Sales activity was enough, however, for industry executives to report confidently in their quarterly conference calls that in this regard the worst consequences of the pandemic are over.

Description: As results emerged showing the influence of COVID-19 on recent mortality, the Society of Actuaries Research Institute’s Mortality and Longevity Strategic Research Program Steering Committee (MLPSC) began to ponder what it means for the future. Was the coronavirus pandemic just a temporary shock to U.S. mortality with mortality quickly returning to prepandemic levels upon its conclusion or a lingering factor in future U.S. mortality from the potential occurrence of new coronavirus variants, post-COVID-19 conditions (“long COVID”), deferral of needed health care treatment, a fatigued health care system and other elements? Only time will provide the answers to these questions.